Factors Affecting Neurological Aging

Colin R. Martin RN, BSc, MSc, PhD, MBA, YCAP, FHEA, C.Psychol, AFBPsS, C.Sci is Professor of Clinical Psychobiology and Applied Psychoneuroimmunology and Clinical Director of the Institute of Health and Wellbeing at the University of Suffolk, UK. He is a Chartered Health Psychologist and a Chartered Scientist. He also trained in analytical biochemistry, this aspect reflecting the psychobiological focus of much of his research within mental health. He has published or has in press well over 300 research papers and book chapters. He is a keen book author and editor having written and/or edited more than 50 books. These outputs include the prophetic insight into the treatment of neurological disease, Handbook of Behavior, Food and Nutrition (2011), Nanomedicine and the Nervous System (2012), Oxidative Stress and Dietary Antioxidants in Neurological Disease (2020), Zika Virus Impact, Diagnosis, Control and Models (2021), Factors Affecting Neurodevelopment: Genetics, Neurology, Behavior and Diet (2021), Diagnosis and Treatment of Spinal Cord Injury (2022), The Neurobiology, Physiology, and Psychology of Pain (2022) and The Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging (2023). Professor Martin is particularly interested in all aspects of the relationship between underlying physiological substrates and behavior, particularly in how these relationships manifest in both acute and chronic psychiatric disorder. He has published original research germane to significant mental health disorders including the areas of schizophrenia, anxiety, depression, self-esteem, alcohol and drug dependency, high secure forensic mental health and personality disorder. He has a keen interest in the impact of postviral illness and is actively involved in clinical research post-Covid pandemic and in particular, the impact of Long Covid on psychological, neurological, physiological and social functioning. He is involved in collaborative International research with many European and Non-European countries. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books. Dr Rajkumar Rajendram is a clinician scientist with a focus on internal medicine, anaesthesia, intensive care and peri-operative medicine. He graduated with distinctions from Guy’s, King’s and St. Thomas Medical School, King’s College London in 2001. As an undergraduate he was awarded several prizes, merits and distinctions in pre-clinical and clinical subjects. Dr Rajendram began his post-graduate medical training in general medicine and intensive care in Oxford. He attained membership of the Royal College of Physicians (MRCP) in 2004 and completed specialist training in acute and general medicine in Oxford in 2010. Dr Rajendram subsequently practiced as a Consultant in Acute General Medicine at the John Radcliffe Hospital, Oxford. Dr Rajendram also trained in anaesthesia and intensive care in London and was awarded a fellowship of the Royal College of Anaesthetists (FRCA) in 2009. He completed advanced training in regional anaesthesia and intensive care. He was awarded a fellowship of the Faculty of Intensive Care Medicine (FFICM) in 2013 and obtained the European diploma of intensive care medicine (EDIC) in 2014. He then moved to the Royal Free London Hospitals as a Consultant in Intensive Care, Anaesthesia and Peri-operative Medicine. He has been a fellow of the Royal College of Physicians of Edinburgh (FRCP Edin) and the Royal College of Physicians of London (FRCP Lond) since 2017 and 2019 respectively. He is currently a Consultant in Internal Medicine at King Abdulaziz Medical City, National Guard Heath Affairs, Riyadh, Saudi Arabia.Dr Rajendram’s focus on improving outcomes from Coronavirus Disease 2019 (COVID-19) has involved research on point of care ultrasound and phenotypes of COVID-19. Dr Rajendram also recognises that nutritional support is a fundamental aspect of medical care. This is particularly important for patients with COVID-19. As a clinician scientist he has therefore devoted significant time and effort into nutritional science research and education. He is an affiliated member of the Nutritional Sciences Research Division of King’s College London and has published over 400 textbook chapters, review articles, peer-reviewed papers and abstracts.

• I. Genetics, Molecular and Cellular Biology1. Genetics of frontotemporal dementia2. Aging, brain-derived neurotrophic factor (BDNF) and its polymorphism3. Aging, demented patients, and polymorphisms in cytokine genes4. RNA fragments and brain aging5. Centrosome functions and remodeling during neuronal development and centrosome abnormalities in neuronal disorders, disease, and in aging6. Brain aging and microarray analysis7. Human nuclear tau and aging8. Lipoxidation: features, neurological tissues and aging9. Aging and brain amino acids10. How 3’,5’-cyclic nucleotide phosphodiesterases change in the brain with normal aging and dementia11. The prohibitin complex in aging and neurodegeneration12. Synaptic ATPase and energy metabolism in the nervous system: roles and changes in the aging processII. Neurological and Imaging Features13. Microstructural Imaging of the Human Brain with Normal and "Abnormal" Aging using Diffusion Magnetic Resonance Imaging14. Imaging the brain and its vascular in aging: Applications of optical coherence tomography angiography15. Potential involvement of perineuronal nets in brain aging: an anatomical point of view16. Grey-matter networks in aging17. Brain synapse-related proteins what they do and how they change in aging18. Macro- and chaperone-mediated autophagy in aging19. Neuronal L-type calcium channels in aging20. D-serine-regulated glutamatergic transmission and microglia: impact of aging21. Voltage-gated potassium channels and the aging brain22. Dendritic spine remodeling and aging23. High-density lipoprotein-cholesterol and neuroaging: memory, gyrification of the insular and frontal opercular cortex24. Astrocyte and microglial aging: morphology and modelling25. Neural scaffolding: features, profiles and the aging cerebellum26. BACE1 RNAi, memory and aging27. Aging, myelination and the optic nerve28. Linking proteostasis, brain aging, and ischemia29. Luteinizing hormone and the aging nervous system30. Insights into aging using transcranial magnetic stimulation31. Alpha rhythms: what they are and how they alter with aging32. Nicotine and its derivatives in healthy brain agingIII. Physiological Aspects33. Environmental enrichment and physiological aging34. Treadmill exercise and neuroinflammation: links with aging35. Impact of aerobic exercise on brain structure in models of aging: hippocampus and beyond36. The physiology of fitness and the brain in aging37. Aging, Babble Noise and the processing of speech perception38. The blood-brain barrier in agingIV. Behavior And Psychopathological Aspects39. Linking aging, anticholinergic drug use, and cognitive impairment40. Cognitive Frailty: Definition, components and impact on disability, and mortality41. The physiology of the "Brain-muscle loop" in aging42. Disentangling the effects of aging and ovarian hormone loss on sleep: Implications for health and disease43. Role of DNA methylation in aging-related cognitive functioning'44. Depression in the elderly and psychobioticsV. Diet And Nutrition45. Aging, dietary patterns and cognition46. Geriatric nutritional risk index: Application, and limitations47. Diet, inflammatory biomarkers, and brain aging48. DASH diet and brain aging49. The ketogenic diet and healthy brain aging50. Autophagy and aging: diet, exercise, and the link with the target of rapamycin complex 1 (TORC)51. Dietary Flavonoids and Brain Health in Ageing: food for Thought52. Antioxidant effects of curcumin and neuroaging53. Lipoic acid and vitamin D3 and their use in preventing brain aging54. Aging and working memory: Impact of the leucine metabolite beta hydroxy-beta-methyl butyrate55. Hydration, the brain and aging